Mitomycin C |
6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1aS,2,8S,8aR,8bS-hexahydro-8a-methoxy-5-methyl-azirino[2’,3’:3,4]pyrrolo[1,2-a]indole-4,7-dione |
(CAS 50-07-7) |
 |
Description: |
Mitomycin C (MMC) is an antitumor antibiotic that was discovered as a fermentation product of S. caespitosus. As an alkylating agent, its activity depends on reductive activation either through low pH or DT-diaphorase or NADH cytochrome c reductase. Activated MMC crosslinks double stranded DNA and is widely used as a tool to selectively inhibit DNA synthesis and mutagenensis, to stimulate genetic recombination, chromosome breakage and sister chromatid exchange, and to induce DNA repair. MMC has clinical significance in combination cancer chemotherapy of solid tumors as well as for modulating wound healing after ophthalmological surgeries and in the management of various corneal disorders.
|
Product No. |
KT20143 |
Product Name |
Mitomycin C |
Synonyms |
MitoExtra; MMC; Ametycine; Mitoplus; NSC 26980; Mitonco |
Formal Name |
6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1aS,2,8S,8aR,8bS-hexahydro-8a-methoxy-5-methyl-azirino[2’,3’:3,4]pyrrolo[1,2-a]indole-4,7-dione |
CAS Number |
50-07-7 |
Molecular Formula |
C15H18N4O5 |
Formula Weight |
334.3 |
Formulation |
A crystalline solid |
Purity |
98%min |
Stability |
2 years |
Storage |
-20°C |
Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
Price & Availability |
In Stock. Price Negotiated. |
|
Related Products: |
Altretamine
Auristatin E
Auristatin F
Busulfan
Carboplatin
Carmustine
Daunorubicin
Doxorubicin
Fotemustine
Melphalan
MMAF
Oxaliplatin
Paclitaxel
Palifosfamide
Satraplatin
Streptozocin
|
|